Cell Applications Introduces Cellular Disease Model for Type 2 Diabetes
Reporter: Evelina B. Cohn, PhD
Press release on December 11, 2015
Cell Application Inc. Company announces on December 11, 2015 the design of human cellular disease model for Type 2 Diabetes. The product grouping consists of human aortic endothelial cells, aortic smooth muscle cells, preadipocytes and skeletal muscle isolated from patient donors affected with the disease.. In addition to high blood sugar 1 in 10 affected individuals encounter complications including high blood pressure, cholesterol, heart attack, stroke, blindness, kidney disease, pregnancy problems, amputation and in severe cases death. This model provides new primary cell based options for life sciences and pharmaceutical drug discovery. The company indicates that additional disease models can be generated on a custom service bases.
VIEW VIDEO
SOURCE
https://www.cellapplications.com/new-diabetes-cell-models#sthash.EcPyBxPO.dpuf
I believe this is just cells which were isolated from patients and not a therapeutic
Thank you for your comment. It is possible. Then, why they are saying: is a model for type 2 diabetes? Are all the cells involved or not in this model? It looks like they are I have to find out somehow. what is the link between these cells in order to have them as a type 2 diabetes model.